Deadline Approaching: Apply for the Fierce AI Innovation Awards
calendar
Biotech

Parabilis’ upsized $670M IPO breaks new for record for biotechs

Parabilis Medicines’ IPO has lived up to the hype—securing $670 million for the largest listing in the biotech sector’s history.
James Waldron Jun 10, 2026 4:36am
Sanofi

Sanofi halts phase 3 autoimmune trial early over lackluster data

Jun 10, 2026 4:25am
FranchiseKeyvisualsOncologyLevel2Digital-nonepng

Could engaging the immune system improve AML outcomes?

Brought to you by Ipsen
Magnifying glass focusing on number 2026 with target icon on yellow background

Despite headwinds, biotech industry charges forward behind M&A

Jun 9, 2026 12:41pm
rollercoaster ride theme park scary crazy

Parabilis ups planned IPO haul to record-setting $637M

Jun 9, 2026 10:22am
AlzeCure

Lilly licenses AlzeCure Alzheimer’s asset for $1B biobucks

Jun 9, 2026 10:16am
More News

ADA: AZ’s oral GLP-1 shows ‘competitive efficacy’ in phase 2

Jun 9, 2026 9:48am

Bial bails after Parkinson’s fail, axing asset over phase 2 miss

Jun 9, 2026 5:22am

GSK inks $10.6B Nuvalent buyout to challenge Roche and Pfizer

Jun 9, 2026 4:41am

Fierce Biotech Fundraising Tracker '26: City, Ona & more

Jun 8, 2026 4:00pm